This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Tarapeutics Science Inc.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Jiang Yan Cao: Innovator in Pharmaceutical Chemistry
Introduction
Jiang Yan Cao is a prominent inventor based in Anhui, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medical applications. His work focuses on creating effective inhibitors for specific kinase activities, which are crucial in various health conditions.
Latest Patents
Jiang Yan Cao holds a patent for "Pyrazole derivatives and use thereof." This patent describes a novel PDGFR kinase inhibitor, which includes a compound of formula (I) or its pharmaceutically acceptable derivatives. The invention provides methods for preventing or treating conditions associated with PDGFR kinase activity, specifically targeting PDGFRα and PDGFRβ kinase activities.
Career Highlights
Throughout his career, Jiang Yan Cao has demonstrated a strong commitment to advancing pharmaceutical research. His innovative approaches have led to the development of compounds that hold promise for treating various diseases. His expertise in the field has positioned him as a valuable contributor to the scientific community.
Collaborations
Jiang Yan Cao has worked alongside notable colleagues, including Qing Song Liu and Jing Liu. Their collaborative efforts have further enhanced the research and development of effective pharmaceutical solutions.
Conclusion
Jiang Yan Cao's contributions to pharmaceutical chemistry, particularly through his patent on PDGFR kinase inhibitors, highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments.